Transform Cancers into Manageable Conditions
Our Mission
Our mission Our mission

Adlai Nortye is a global clinical-stage biopharmaceutical company that is developing differentiated, innovative immuno-oncology medicines. Adlai Nortye focuses on discovering and developing important new treatments for cancer with a mission to improve patient lives by identifying and developing differentiated innovative medicines that help people live better, live longer. Through close collaborations with global partners, Adlai Nortye has successfully positioned itself in the field of immuno-oncology and has several programs ongoing from early pre-clinical to phase III ready.


To be a leading global presence in the immuno-oncology market
Our Vision
Our vision Our vision
Introduction to our mission
2020
Introduction to our mission
2019
Introduction to our mission
2018
Introduction to our mission
2017
Introduction to our mission
2016